Perlin designs enzymes to simplify pharmaceutical manufacturing. Many industrial reactions have no enzyme available: none exists off the shelf, and there is nothing close enough to evolve one from. We design them from scratch. Enzyme design is a multi-objective optimization problem. We've built on our peer-reviewed research to create a scalable pipeline that orchestrates diffusion, inverse-folding, and co-folding models, designing Pareto-optimal enzymes around a target conversion. Every candidate is validated in our own lab. The result is shorter routes, better selectivity, and fewer heavy metal catalysts to remove downstream. Say hello@perlin.bio or have a look at perlin.bio
| Website | https://perlin.bio/ |
| Employees | 4 (4 on RocketReach) |
| Founded | 2026 |
| Industry | Biotechnology Research |
Looking for a particular Hephaistos employee's phone or email?
Jannik Neumann is the CEO and Co-Founder of Hephaistos.
4 people are employed at Hephaistos.
Hephaistos is based in Basel, Basel City.